SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-029084
Filing Date
2016-11-14
Accepted
2016-11-14 06:55:23
Documents
3
Period of Report
2016-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q3 2016 EARNINGS RELEASE reta-8k_20161114.htm 8-K 34652
2 EX-99.1 reta-ex991_33.htm EX-99.1 227266
3 GRAPHIC g201611140122293771884.jpg GRAPHIC 6766
  Complete submission text file 0001564590-16-029084.txt   272502
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 161990356
SIC: 2834 Pharmaceutical Preparations